- Types of drug interaction
- Interactions with illegal and recreational drugs
- Testing drug levels
- Summary: Testing drug levels
- How are drugs absorbed?
- Variability in protease inhibitor levels
- Measuring protease inhibitor levels
- Cmin and antiviral activity
- Gender differences in drug levels
- Testing levels of other drugs
- The link with adherence
- Access to drug monitoring in the United Kingdom
- Key research on testing for drug levels
Testing drug levels
- Summary: Testing drug levels
- How are drugs absorbed?
- Variability in protease inhibitor levels
- Measuring protease inhibitor levels
- Cmin and antiviral activity
- Gender differences in drug levels
- Testing levels of other drugs
- The link with adherence
- Access to drug monitoring in the United Kingdom
- Key research on testing for drug levels
latest aidsmap news
- US Health Department identifies further 18 effective HIV prevention programmes
- More African people acquiring HIV in the UK than previously thought
- HIV prevalence may decline because the most vulnerable are infected and die first
- Lack of perceived need for HIV treatment associated with poor adherence
- TB doesn't always increase HIV viral load
- New 75mg darunavir tablet approved by FDA for use by HIV-positive children
- Thyroid checks recommended for people with HIV
- Knighthood for head of UK HIV charity
- Gay men often not accessing PEP despite risk of HIV exposure
- Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV
